HomeInsightsEPS

Zydus Lifesciences Ltd EPS

Zydus Lifesciences Ltd EPS

stocks purchased

₹ 5.3 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

54.0 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

EPS

₹ 42.51

Last updated on: Dec 20, 2024

Key Highlights

  • The Earning per Share of Zydus Lifesciences Ltd is ₹ 42.51 as of 20 Dec 24 .
  • The earning per share of Zydus Lifesciences Ltd changed from ₹ 5.06 to ₹ 9.06 over 10 quarters. This represents a CAGR of 26.24% .

Historical Earning per Share of Zydus Lifesciences Ltd

No data available

* All values are in

Company Fundamentals for Zydus Lifesciences Ltd

Market Cap

97,997 Cr

EPS

42.5

P/E Ratio (TTM) *

22.9

P/B Ratio (TTM) *

4.5

Day’s High *

992.05

Day’s Low

971.15

DTE *

0.0

ROE *

19.7

52 Week High

1323.9

52 Week Low

648.05

ROCE *

25.0

Market Price of Zydus Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 2024973.9
19 Dec 2024985.7
18 Dec 2024979.1
17 Dec 2024969.5
16 Dec 2024988
13 Dec 2024978.35
12 Dec 2024975.65
11 Dec 2024986.3
10 Dec 2024974.7
09 Dec 2024982.9

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Zydus Lifesciences Ltd

Market Value

97,997

Asset Value

15,429

5.4 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Zydus Lifesciences Ltd4297,997
Sun Pharmaceuticals Industries Ltd464,33,920
Divis Laboratories Ltd691,55,160
Cipla Ltd571,18,917
Torrent Pharmaceuticals Ltd511,16,225
Mankind Pharma Ltd521,12,324

Historical Market Cap of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Revenue of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Zydus Lifesciences Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Zydus Lifesciences Ltd News Hub

News

Zydus Life gets USFDA nod for Lidocaine and Prilocaine Cream USP

Lidocaine and Prilocaine Cream USP is indicated as a topical anaesthetic for use on normal...

Read more

19 Dec 2024 12:49

News

Zydus Lifesciences receives USFDA approval for Lidocaine and Prilocaine Cream

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

19 Dec 2024 14:58

News

Zydus Animal Health and Investment to divest its stake held in Mylan

Zydus Lifesciences announced that Zydus Animal Health and Investments, a wholly owned subs...

Read more

16 Dec 2024 12:50

News

Zydus Lifesciences Ltd spurts 1.03%, rises for third straight session

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs...

Read more

03 Dec 2024 13:06

News

Zydus Lifesciences receives Rs 1.61-cr GST demand for FY 2017-18

The issue pertains to the Input Tax Credit (ITC) carried forward through the TRAN-1 form. ...

Read more

29 Nov 2024 12:04

News

Zydus Life Q2 PAT rises 14% YoY to Rs 911 cr

Revenue from operations grew 19.87% year on year (YoY) to Rs 5,237 crore in the quarter en...

Read more

12 Nov 2024 15:22

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Sep 2021

Transcript

Jan 2021

PPT

Aug 2020

PPT

Feb 2020

PPT

FAQs for EPS of Zydus Lifesciences Ltd

What is the EPS of Zydus Lifesciences Ltd stock?

The Earnings Per Share (EPS) of Zydus Lifesciences Ltd is 42.51. An EPS is the amount of net income attributed to each share of a common stock.

How is Zydus Lifesciences Ltd EPS calculated?

The EPS of Zydus Lifesciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Zydus Lifesciences Ltd report its EPS?

Zydus Lifesciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Zydus Lifesciences Ltd EPS?

Factors that influence the EPS of Zydus Lifesciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Zydus Lifesciences Ltd EPS growth indicate future performance?

Yes, consistent growth in Zydus Lifesciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions